TOLEROGENER DNA-IMPFSTOFF

European patent · EP3534936 · In force

Register entry

Publication number
EP3534936
Application number
EP17801363
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 1, 2017
Published
Sep 11, 2019
Granted
Oct 21, 2020
Protection ends at the latest
Oct 31, 2037
Next annual fee due
Nov 30, 2026
IPC classes
A61K 39/00 (2006.01)
A61P 3/10 (2006.01)
Priority
US 201662415717 P 01.11.2016
EP 17150037 02.01.2017
EP 17169019 02.05.2017
EP 17177289 22.06.2017
EP 17198041 24.10.2017
PCT application
PCT/EP2017/077949 01.11.2017
PCT publication
WO2018/083111 11.05.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. Oct 21, 2020

    Granted

    Published in Swissreg on 21.10.2020

Parties

Holder

Novo Nordisk A/S

Novo Allé, 2880 Bagsværd, DK

Inventor

CHAPLIN, Jay

2880 Bagsværd, DK

WIJARANAKULA, Michael

2880 Bagsværd, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.